Novanta Inc (NOVT)

Industry Scientific & Technical Instruments
This stock can be held in an Investment ISA and an Investment Account
Sell

$53.05

Buy

$212.17

arrow-up$1.22 (+0.93%)

Novanta Inc,designs, develops, manufactures and sells precision photonic and motion control components and subsystems to original equipment manufacturers in the medical, industrial, electronics and scientific markets.
Prices updated at 13 May 2025, 21:05 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-up1.61%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Technology
Industry
Scientific & Technical Instruments
Chairman
Mr. Matthijs Glastra
CEO
Mr. Matthijs Glastra
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
3,000
Head office
125 Middlesex Turnpike
Bedford
United States
01730
mobile
+1 781 266-5700
letter
-
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Lonny J. Carpenter
Lead Independent Director
0.12m--0.32m-
Mr. Frank Anders Wilson
Independent Director
0.10m--0.30m-
Mr. Robert J. Buckley
Chief Financial Officer
0.55m--3.91m-
Dr. Darlene J.S. Solomon, PhD
Independent Director
0.08m--0.28m-
Mr. Thomas N. Secor
Independent Director
0.08m--0.28m-
Mr. Matthijs Glastra
Chairman of the Board and Chief Executive Officer
0.83m--8.78m-
Ms. Maxine Lum Mauricio
Independent Director
0.08m--0.28m-
Ms. Barbara B. Hulit
Independent Director
0.08m--0.28m-
Ms. Mary Katherine Ladone
Independent Director
0.03m--0.13m-
Ms. Michele Davis Welsh
General Counsel and Corporate Secretary
0.38m--1.39m-
Mr. R. Matthew Johnson
Independent Director
0.04m--0.17m-
Mr. John Joseph Burke, II
Chief Accounting Officer
-----
Mr. John Lesica
Co-Chief Operating Officer, Medical Solutions
-----
Mr. Chuck Ravetto
Co-Chief Operating Officer, Automation Enabling Technologies
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
BlackRock Inc4,579,0650.01416807021.7940330 Apr 202512.73
Vanguard Group Inc4,092,6500.00946-31178-0.75604530 Apr 202511.38
BlackRock Fund Advisors2,724,7001.88011-2594-30 Apr 20257.57
T Rowe Price Associates, Inc2,065,133-2065133-30 Apr 20255.75
T. Rowe Price Associates, Inc.1,907,8410.0336-157292-7.61655530 Apr 20255.30

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
11 Dec 2024-Mr. Robert J. Buckley--36,219--
11 Dec 2024-Mr. Robert J. Buckley--84,200--
05 Dec 2024-Mr. Matthijs Glastra--12,000--
05 Dec 2024-Mr. Matthijs Glastra--15,693--
04 Dec 2024-Mr. Robert J. Buckley--12,803--
04 Dec 2024-Mr. Robert J. Buckley14.1322,848122,036--
04 Dec 2024-Mr. Robert J. Buckley170.16275,149120,419--
02 Dec 2024-Mr. Robert J. Buckley169.9272,556120,419--
02 Dec 2024-Mr. Robert J. Buckley167.9596,739121,326--
02 Dec 2024-Mr. Robert J. Buckley166.8464,400121,902--
02 Dec 2024-Mr. Robert J. Buckley165.8728,530122,288--
02 Dec 2024-Mr. Robert J. Buckley14.1328,839122,460--
02 Dec 2024-Mr. Robert J. Buckley--14,420--
02 Dec 2024-Mr. Robert J. Buckley169.0281,130120,846--
02 Dec 2024-Mr. Matthijs Glastra166.2734,41856,175--
02 Dec 2024-Mr. Matthijs Glastra167.2929,10856,001--
02 Dec 2024-Mr. Matthijs Glastra168.43113,69055,326--
02 Dec 2024-Mr. Matthijs Glastra169.28159,80054,382--
11 Nov 2024-Mr. Matthijs Glastra179.30178,76259,378--
11 Nov 2024-Mr. Matthijs Glastra183.16164,84456,382--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.